BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16364742)

  • 1. Viral persistence: parameters, mechanisms and future predictions.
    Oldstone MB
    Virology; 2006 Jan; 344(1):111-8. PubMed ID: 16364742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling.
    Hahm B; Trifilo MJ; Zuniga EI; Oldstone MB
    Immunity; 2005 Feb; 22(2):247-57. PubMed ID: 15723812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How the bovine viral diarrhea virus outwits the immune system].
    Peterhans E; Jungi TW; Schweizer M
    Dtsch Tierarztl Wochenschr; 2006 Apr; 113(4):124-9. PubMed ID: 16716045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taking the brake off T cells in chronic viral infection.
    Shin EC; Rehermann B
    Nat Med; 2006 Mar; 12(3):276-7. PubMed ID: 16520769
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.
    Schildknecht A; Probst HC; McCoy KD; Miescher I; Brenner C; Leone DP; Suter U; Ohashi PS; van den Broek M
    Eur J Immunol; 2009 Jun; 39(6):1505-15. PubMed ID: 19462379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis.
    Zinkernagel MS; Bolinger B; Krebs P; Onder L; Miller S; Ludewig B
    J Virol; 2009 Jan; 83(1):159-66. PubMed ID: 18945766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections.
    Unsoeld H; Mueller K; Schleicher U; Bogdan C; Zwirner J; Voehringer D; Pircher H
    Int Immunol; 2007 Nov; 19(11):1281-9. PubMed ID: 17914120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection.
    Wilson EB; Kidani Y; Elsaesser H; Barnard J; Raff L; Karp CL; Bensinger S; Brooks DG
    Cell Host Microbe; 2012 May; 11(5):481-91. PubMed ID: 22607801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 plays an early role in generating virus-specific T cell anergy.
    Maris CH; Chappell CP; Jacob J
    BMC Immunol; 2007 Jun; 8():8. PubMed ID: 17570849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent LCMV infection is controlled by blockade of type I interferon signaling.
    Teijaro JR; Ng C; Lee AM; Sullivan BM; Sheehan KC; Welch M; Schreiber RD; de la Torre JC; Oldstone MB
    Science; 2013 Apr; 340(6129):207-11. PubMed ID: 23580529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone.
    Scandella E; Bolinger B; Lattmann E; Miller S; Favre S; Littman DR; Finke D; Luther SA; Junt T; Ludewig B
    Nat Immunol; 2008 Jun; 9(6):667-75. PubMed ID: 18425132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cells.
    Graham VA; Marzo AL; Tough DF
    Eur J Immunol; 2007 Apr; 37(4):925-34. PubMed ID: 17330818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-21 mRNA expression during virus infections.
    Holm C; Nyvold CG; Paludan SR; Thomsen AR; Hokland M
    Cytokine; 2006 Jan; 33(1):41-5. PubMed ID: 16406655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of chronic type I interferon signaling to control persistent LCMV infection.
    Wilson EB; Yamada DH; Elsaesser H; Herskovitz J; Deng J; Cheng G; Aronow BJ; Karp CL; Brooks DG
    Science; 2013 Apr; 340(6129):202-7. PubMed ID: 23580528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Langerhans cell UV injury and dendritic cell infection by immunosuppressive viruses induce immunologic tolerance? First part.
    Mathé G
    Biomed Pharmacother; 2000 Jul; 54(6):287-90. PubMed ID: 10989960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interfering with type I interferon: a novel approach to purge persistent viral infection.
    Wilson EB; Brooks DG
    Cell Cycle; 2013 Sep; 12(18):2919-20. PubMed ID: 23974094
    [No Abstract]   [Full Text] [Related]  

  • 17. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring function in exhausted CD8 T cells during chronic viral infection.
    Barber DL; Wherry EJ; Masopust D; Zhu B; Allison JP; Sharpe AH; Freeman GJ; Ahmed R
    Nature; 2006 Feb; 439(7077):682-7. PubMed ID: 16382236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Experimental LCMV Infection of Mice: The Role of Mathematical Models.
    Bocharov G; Argilaguet J; Meyerhans A
    J Immunol Res; 2015; 2015():739706. PubMed ID: 26576439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice.
    Lee LN; Burke S; Montoya M; Borrow P
    J Immunol; 2009 Jun; 182(11):7178-89. PubMed ID: 19454715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.